| Not Yet Recruiting | Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Fa NCT07117695 | Duke University | N/A |
| Not Yet Recruiting | Chronic Kidney Disease and Metabolic Disorders in the Elderly NCT07494526 | Chinese PLA General Hospital | — |
| Not Yet Recruiting | A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C NCT07312773 | Addpharma Inc. | Phase 1 |
| Not Yet Recruiting | "Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization P NCT07273513 | China National Center for Cardiovascular Diseases | N/A |
| Recruiting | A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia NCT07230730 | Beijing Suncadia Pharmaceuticals Co., Ltd | Phase 3 |
| Recruiting | Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of NCT07334834 | Colorado Prevention Center | N/A |
| Recruiting | A Study to Evaluate COR-1004 in Adult Volunteers. NCT07229118 | Corsera Health | Phase 1 |
| Recruiting | A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia NCT07229937 | Shandong Suncadia Medicine Co., Ltd. | Phase 2 |
| Recruiting | Inspire HER: Inspiring the Heart and Emotions for Radical Health NCT06966258 | University of Alabama at Birmingham | N/A |
| Recruiting | A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037) NCT07216482 | Merck Sharp & Dohme LLC | Phase 3 |
| Not Yet Recruiting | 2-HOBA Supplementation in People With Elevated Lipoprotein(a) NCT07198009 | The Miriam Hospital | N/A |
| Completed | A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects NCT07097831 | Shandong Suncadia Medicine Co., Ltd. | Phase 1 |
| Enrolling By Invitation | Truway Diagnostic Tools in Primary Care NCT07209527 | Truway Health, Inc. | EARLY_Phase 1 |
| Recruiting | "Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Byp NCT06615609 | China National Center for Cardiovascular Diseases | N/A |
| Withdrawn | Impact of Cholesterol Level on Long-term Coronary Bypass Graft Patency NCT05393882 | Chinese University of Hong Kong | — |
| Recruiting | A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia NCT07100418 | Fujian Shengdi Pharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial NCT07119658 | Indiana University | N/A |
| Not Yet Recruiting | Intervention Study on Digital Health Management NCT06949306 | Shanghai 10th People's Hospital | N/A |
| Not Yet Recruiting | Effect of Smartphone Application (MED-AD) on Medication Adherence Among Patients With Cardiovascular Disease i NCT06951451 | Sultan Qaboos University | N/A |
| Recruiting | Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision NCT07400549 | China National Center for Cardiovascular Diseases | N/A |
| Recruiting | Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT NCT06603363 | Prof. Maurovich-Horvat Pál | N/A |
| Not Yet Recruiting | Preventative Screening and Health Coaching in a Food Insecure Population NCT06907524 | Rush University Medical Center | N/A |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy Subje NCT06857253 | Shandong Suncadia Medicine Co., Ltd. | Phase 1 |
| Enrolling By Invitation | Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative NCT06831162 | Vanderbilt University Medical Center | N/A |
| Completed | HeartBeet Clinic Pilot Trial NCT06486532 | HealthPartners Institute | N/A |
| Recruiting | Rapid Escalation of LipiD Lowering Therapy to Reduce RecUrrent Cardiovascular Event NCT07311941 | Chinese University of Hong Kong | — |
| Recruiting | To Understand the Self-care Ability of Farmers and Fishermen With CMDs (Hypertension, Heart Disease, Hyperlipi NCT06703151 | Chang Gung Memorial Hospital | N/A |
| Recruiting | Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance NCT06684106 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Completed | Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention NCT06647238 | Wake Forest University Health Sciences | N/A |
| Recruiting | Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 NCT06694012 | Osaka Metropolitan University | — |
| Enrolling By Invitation | LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer NCT06876675 | Peking University Third Hospital | — |
| Completed | The Clinical Study on Isoflavone Genistein in Restructuring the Gut Microbiota of Hyperlipidemia Patients NCT06895954 | Shenzhen Hospital of Southern Medical University | N/A |
| Recruiting | Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients NCT07180368 | Xijing Hospital | — |
| Not Yet Recruiting | Effect of Small Interfering RNA Inclisiran on Carotid Plaques As Assessed by Carotid Ultrasound NCT06586684 | First Affiliated Hospital of Xinjiang Medical University | Phase 4 |
| Completed | A Study on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7249 Injection in Healthy Subjec NCT06541457 | Fujian Shengdi Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study NCT06752772 | Alexandra Hospital | N/A |
| Enrolling By Invitation | Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine NCT06782646 | The University of Hong Kong | Phase 2 / Phase 3 |
| Completed | Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia NCT06471218 | Beijing Suncadia Pharmaceuticals Co., Ltd | Phase 2 |
| Recruiting | Whole Grain Job's Tear, Muscle Health, Blood Glucose and Lipid Level NCT06503172 | Taipei Veterans General Hospital, Taiwan | Phase 2 |
| Recruiting | AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medic NCT06614049 | National University of Singapore | N/A |
| Unknown | The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory NCT06224296 | Shanghai Cell Therapy Group Co.,Ltd | N/A |
| Completed | Evaluation of the Hypolipidemic Effect of Bergavit by a Human Trial. NCT06692777 | Chung Shan Medical University | N/A |
| Unknown | Study on Hyperlipidemia Combined With Carotid Atherosclerosis With ShenJu Granules NCT06166121 | Guangdong Provincial Hospital of Traditional Chinese Medicine | N/A |
| Unknown | A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of JS401 NCT06041165 | Shanghai Junshi Bioscience Co., Ltd. | Phase 1 |
| Recruiting | Effect of Nigella Sativa in Atorvastatin Treated Hyperlipidaemia NCT06422650 | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Phase 2 |
| Unknown | Evaluation of Health Effects of Adlay on Hyperlipidemia and Hyperglycemia Control NCT05990595 | National Taiwan University Hospital | N/A |
| Unknown | Telehealth Integrated Care Model in Patients With Cardiometabolic Disease NCT06022575 | Peking University Third Hospital | — |
| Completed | Nigella Sativa Supplementation in Hyperlipidemia Treatment NCT06890546 | Istanbul Bilgi University | N/A |
| Recruiting | Observation on the Correlation Between Serum/Fecal Isoflavones, Abundance of TMA-producing Bacteria and Serum NCT06890780 | Zhujiang Hospital | — |
| Completed | Metabolic Syndrome and Related Diseases in Healthcare Workers NCT06543706 | Peking Union Medical College Hospital | — |
| Unknown | Effects of Non-surgical Periodontal Therapy on Severe Periodontitis and Hyperlipidemia NCT05548933 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Completed | Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study NCT05535660 | Icahn School of Medicine at Mount Sinai | — |
| Completed | Pumpkin Seeds or Oil Lower Serum Triglyceride Levels in Individuals With Hyperlipidaemia NCT07123844 | Kastamonu University | N/A |
| Completed | Unmet Social Needs Study NCT04977583 | VA Office of Research and Development | N/A |
| Completed | A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia NCT05260411 | Akeso | Phase 3 |
| Completed | A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia NCT05255458 | Akeso | Phase 3 |
| Completed | A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia NCT05255094 | Akeso | Phase 3 |
| Completed | A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C NCT04998981 | Kowa Company, Ltd. | Phase 3 |
| Completed | Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants Wit NCT04774003 | Novartis Pharmaceuticals | Phase 1 |
| Completed | PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health NCT04673721 | Duke University | N/A |
| Completed | Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers NCT04692025 | Gannex Pharma Co., Ltd. | Phase 1 |
| Completed | Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects NCT04686994 | Gannex Pharma Co., Ltd. | Phase 1 |
| Unknown | Impact of a Chewable Plant Sterol Supplement on LDL-C in A Real-World Setting NCT04642742 | Piper Biosciences, Inc. | — |
| Completed | Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DC371739 Single-Dose Treatment NCT04640012 | Guangzhou JOYO Pharma Co., Ltd | Phase 1 |
| Completed | Medication Adherence Clinical Decision Support NCT03748420 | HealthPartners Institute | N/A |
| Unknown | Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia NCT04438096 | CVI Pharmaceuticals | Phase 2 |
| Completed | The Antihypercholestrolemic Effect of a Combined Nutritional Supplementation of Standardized Extracts of Amla, NCT06002893 | Liaquat University of Medical & Health Sciences | N/A |
| Completed | Tennis Elbow Patients Undergoing Closed Therapy Can Easily Cause Tendon Tear NCT04457024 | Peking University Third Hospital | — |
| Unknown | Effect of InnoSlim® on Blood Sugar and Blood Lipids Regulation in Humans NCT04201314 | Chung Shan Medical University | N/A |
| Completed | The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperli NCT03944109 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 / Phase 2 |
| Unknown | Ezetimibe and Orlistat Affect the Intestinal Flora of Hyperlipidemia. NCT03884127 | Fifth Affiliated Hospital of Xinjiang Medical University | — |
| Completed | Effect of Evolocumab on Coronary Atherosclerosis NCT03689946 | Cedars-Sinai Medical Center | Phase 3 |
| Completed | Lipid-Lowering Effect and Hypotensive Effect of Shanzha Fruit Drink in Patients NCT04672278 | Chinese University of Hong Kong | N/A |
| Terminated | Virtual Visits at Brigham and Women's Hospital NCT03592355 | Brigham and Women's Hospital | N/A |
| Completed | Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With NCT03225157 | National Institute on Deafness and Other Communication Disorders (NIDCD) | — |
| Unknown | Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia NCT03639480 | HK inno.N Corporation | Phase 3 |
| Completed | Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid Status NCT03213288 | Quadram Institute Bioscience | N/A |
| Completed | Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers NCT02449187 | Jeil Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male NCT02982798 | Jeil Pharmaceutical Co., Ltd. | Phase 1 |
| Unknown | Hospital-level Variation in the Management of Blood Pressure and Low-density Lipoprotein in the Outpatient Hyp NCT03862183 | Huashan Hospital | — |
| Completed | Effect of Intake of Citron(Citrus Junos Siebold ex Tanaka) Peel Extract on Blood Cholesterol. NCT03332641 | Hanyang University | N/A |
| Completed | Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of NCT03116516 | Yuhan Corporation | Phase 1 |
| Completed | Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia NCT03067688 | Yuhan Corporation | Phase 3 |
| Completed | Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Bloo NCT02839902 | Takeda | Phase 4 |
| Unknown | Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab NCT02992301 | Westside Medical Associates of Los Angeles | Phase 4 |
| Unknown | Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II) NCT02959762 | Augusta University | N/A |
| Completed | Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver NCT02927184 | Viking Therapeutics, Inc. | Phase 2 |
| Completed | Bioequivalence Study of CJ-30061 in Healthy Male Volunteers NCT03657472 | HK inno.N Corporation | Phase 1 |
| Unknown | A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia NCT02979704 | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Phase 2 / Phase 3 |
| Completed | Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Pat NCT02824432 | Takeda | Phase 4 |
| Completed | A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin NCT02951962 | Yuhan Corporation | Phase 1 |
| Completed | Patient-Centred Innovations for Persons With Multimorbidity - Quebec NCT02789800 | Université de Sherbrooke | N/A |
| Completed | The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production NCT03141827 | University Health Network, Toronto | Phase 2 / Phase 3 |
| Completed | Impact of MayoExpertAdvisor on Provider Adherence NCT02742545 | Mayo Clinic | N/A |
| Completed | Improving Quality by Maintaining Accurate Problems in the EHR NCT02596087 | Brigham and Women's Hospital | N/A |
| Completed | Effect of Butter & MCT Oil on Lipoproteins - A RCT NCT02611102 | Walter Reed National Military Medical Center | N/A |
| Withdrawn | Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dy NCT02799758 | Kowa Research Institute, Inc. | Phase 3 |
| Completed | Patient-Centred Innovations for Persons With Multimorbidity - Ontario NCT02742597 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | N/A |
| Completed | Low Fat Plant-Based Supplemented Diet Effects on Risk Factors for Chronic Non-communicable Diseases NCT02905448 | Barbara Jakše s.p. | N/A |
| Withdrawn | Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia NCT02670434 | Kowa Research Institute, Inc. | Phase 3 |
| Completed | A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers NCT02634034 | Kowa Research Institute, Inc. | Phase 1 |
| Completed | A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg NCT02659397 | Esperion Therapeutics, Inc. | Phase 2 |
| Completed | The SCCS Polypill Pilot Trial NCT02278471 | Vanderbilt University | Phase 2 |
| Terminated | PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin NCT02608242 | Yuhan Corporation | Phase 1 |
| Completed | A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuva NCT02569814 | Boryung Pharmaceutical Co., Ltd | Phase 1 |
| Completed | A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet NCT02566187 | Boryung Pharmaceutical Co., Ltd | Phase 1 |
| Completed | Tele-Pharmacy Intervention to Improve Treatment Adherence NCT02512276 | Brigham and Women's Hospital | N/A |
| Unknown | Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia NCT02532218 | Arisaph Pharmaceuticals Inc | Phase 2 |
| Completed | Rosuvastatin Adherence App Study in China NCT02433288 | AstraZeneca | N/A |
| Terminated | Dietary Sources of Lysophospholipids NCT02952638 | Susan Smyth | — |
| Completed | Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Sub NCT02458287 | Pfizer | Phase 3 |
| Completed | Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Pro NCT02437084 | Stanford University | Phase 4 |
| Completed | The Northwest Coalition for Primary Care Practice Support NCT02839382 | Kaiser Permanente | N/A |
| Completed | Patient and Provider Assessment of Lipid Management Registry NCT02341664 | Duke University | — |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 NCT02451098 | Chong Kun Dang Pharmaceutical | Phase 3 |
| Completed | Acute Microvascular Changes With LDL Apheresis NCT02388633 | Oregon Health and Science University | — |
| Completed | Effects of Use of a Connected Pillbox On Medication Adherence NCT02593032 | University of Pennsylvania | N/A |
| Completed | The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine NCT02387619 | Jeil Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | MEDication Focused Outpatient Care for Underutilization of Secondary Prevention NCT02215408 | Korey Kennelty | N/A |
| Completed | A Mobile Personal Health Record for Behavioral Health Homes NCT01890226 | Emory University | N/A |
| Unknown | Comparison of LDL Particle Count With Other Available Lipid Tests NCT02298894 | Scripps Clinic | — |
| Completed | Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed NCT02100514 | Pfizer | Phase 3 |
| Completed | Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3 NCT02285166 | Takeda | — |
| Active Not Recruiting | Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy NCT02262806 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Active Not Recruiting | Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy NCT02262832 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Terminated | A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol NCT02227784 | Eli Lilly and Company | Phase 3 |
| Completed | Safety for 24 Weeks Intake of Korean Red Ginseng in Adults NCT02428998 | Korea Ginseng Corporation | N/A |
| Completed | Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia NCT02280590 | Dong-A ST Co., Ltd. | Phase 4 |
| Completed | Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on t NCT02275156 | Amgen | Phase 1 |
| Unknown | Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia NCT02203227 | Olive Lifesciences Pvt Ltd | N/A |
| Completed | Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin NCT02186483 | Jeil Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hyper NCT02899455 | Hanmi Pharmaceutical Company Limited | Phase 3 |
| Completed | A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism NCT02366156 | Access Business Group | N/A |
| Completed | Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins NCT02135029 | Pfizer | Phase 3 |
| Completed | Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia NCT02942602 | Yonsei University | N/A |
| Completed | Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subje NCT02676596 | Kowa Research Institute, Inc. | Phase 1 |
| Unknown | Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia NCT02100202 | Olive Lifesciences Pvt Ltd | N/A |
| Completed | CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin) NCT02047175 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Unknown | Nutraceuticals to Improve Lipid Profile in European Countries NCT01649986 | University of Roma La Sapienza | Phase 4 |
| Withdrawn | Study of the Effects of Blackcurrant Extract and Omega-3 Fats on the Health of the Heart and Blood Vessels NCT02019680 | National Institute of Nursing Research (NINR) | — |
| Completed | Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3 NCT01984424 | Amgen | Phase 3 |
| Completed | Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002 NCT02044627 | Esperion Therapeutics, Inc. | Phase 1 |
| Completed | Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypert NCT01914432 | Yuhan Corporation | Phase 3 |
| Completed | Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than Normal Blood Lipid Levels NCT02187757 | PreEmptive Meds, Pvt. Ltd | Phase 3 |
| Completed | Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipi NCT01968967 | Pfizer | Phase 3 |
| Completed | Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipi NCT01968954 | Pfizer | Phase 3 |
| Completed | Effect of Different Types of Carbohydrates Consumed After Exercise on Blood Fat Levels NCT02012855 | University of Saskatchewan | N/A |
| Completed | Improving Heart Health in Appalachia NCT01884246 | Debra Moser | N/A |
| Unknown | Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardi NCT01890889 | Integrative Health Technologies, Inc. | N/A |
| Completed | Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl Esters NCT02153073 | Takeda | — |
| Unknown | Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia NCT02087540 | IlDong Pharmaceutical Co Ltd | Phase 3 |
| Completed | Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. NCT01842256 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine NCT01842230 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Effect Of Capros Supplementation On Cardiovascular Disease Risk Factors In Humans NCT01858376 | Chandan K Sen | N/A |
| Completed | Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2 NCT01763918 | Amgen | Phase 3 |
| Completed | Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2 NCT01763905 | Amgen | Phase 3 |
| Completed | To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet NCT01764178 | JW Pharmaceutical | Phase 1 |
| Completed | Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy fo NCT01763827 | Amgen | Phase 3 |
| Completed | LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2 NCT01763866 | Amgen | Phase 3 |
| Completed | Effect of Cheese on Cardiovascular Risk NCT01739153 | University of Copenhagen | N/A |
| Unknown | RCT Examining Effects of Probiotics in T2DM Individuals NCT01752803 | Universiti Kebangsaan Malaysia Medical Centre | N/A |
| Completed | Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Vals NCT01918358 | LG Life Sciences | Phase 1 |
| Unknown | Efficacy and Safety of Kochujang Pills on Improvement of Blood Lipids NCT01735149 | Chonbuk National University Hospital | Phase 2 / Phase 3 |
| Completed | Financial Incentives for Medication Adherence NCT01678183 | Boston Medical Center | N/A |
| Completed | Prioritized Clinical Decision Support (CDS) to Reduce Cardiovascular Risk NCT01420016 | HealthPartners Institute | N/A |
| Completed | Effect of Citrus Bioflavonoids/Vitamin E in Conjunction With Fish Oil Supplementation NCT01671254 | MetaProteomics LLC | N/A |
| Completed | Translating a Heart Disease Lifestyle Intervention Into the Community NCT01647438 | Northwestern University | N/A |
| Completed | Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorde NCT01571609 | University of Aarhus | N/A |
| Completed | Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy NCT01634906 | Sint Franciscus Gasthuis | N/A |
| Completed | Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans NCT01600703 | University Health Network, Toronto | Phase 2 / Phase 3 |
| Completed | Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study. NCT02582424 | Primus Pharmaceuticals | N/A |
| Completed | Veterans Service Organizations and My HealtheVet (MHV) NCT01597843 | US Department of Veterans Affairs | N/A |
| Completed | Prevention Trial to Achieve Cardiovascular Targets NCT01642355 | NYU Langone Health | N/A |
| Completed | Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome NCT01845428 | University of North Carolina, Chapel Hill | Phase 1 |
| Unknown | The Effect of Extract of Green Tea on Obese Women and Obese Related Hormone Peptides NCT02147041 | Taipei City Hospital | Phase 2 / Phase 3 |
| Completed | Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz NCT01695954 | NYU Langone Health | Phase 1 |
| Unknown | Meta-analyses of Total and Individual Fructose-containing Sugars and Incident Cardiometabolic Disease NCT01608620 | John Sievenpiper | — |
| Completed | The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications NCT01586897 | Massachusetts General Hospital | N/A |
| Completed | Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia NCT01918332 | LG Life Sciences | Phase 3 |
| Completed | A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-04 NCT01806324 | HanAll BioPharma Co., Ltd. | Phase 1 |
| Completed | A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes NCT01607294 | Esperion Therapeutics, Inc. | Phase 2 |
| Completed | Safety and Efficacy Study of Herbal Supplements in Prediabetic and Mild to Moderate Hyperlipidemic Patients NCT01680211 | Olive Lifesciences Pvt Ltd | N/A |
| Completed | Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia NCT01541943 | HanAll BioPharma Co., Ltd. | Phase 3 |
| Completed | Genetic Influences on Statin Blood Concentrations in African Americans NCT01569867 | Ohio State University | — |
| Withdrawn | Genetic Influence on Statin Pharmacodynamics NCT01569854 | Ohio State University | — |
| Completed | Combined Effects of Bioactive Compounds in Lipid Profile NCT01562080 | Rottapharm Spain | Phase 2 / Phase 3 |
| Completed | Efficacy and Safety of Kochujang Pills on Blood Lipids Profiles in Hyperlipidemia Subjects NCT01865370 | Chonbuk National University Hospital | Phase 2 / Phase 3 |
| Completed | Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan NCT01609907 | Yuhan Corporation | Phase 1 |
| Completed | Cardiovascular Intervention Improvement Telemedicine Study NCT01142908 | VA Office of Research and Development | N/A |
| Completed | Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients NCT01448174 | Poznan University of Medical Sciences | Phase 4 |
| Completed | A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol NCT01426412 | Eli Lilly and Company | Phase 1 |
| Completed | Regulation of Intestinal and Hepatic Lipoprotein Production by Glucose and Fructose NCT01694446 | University Health Network, Toronto | N/A |
| Completed | Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects NCT01406431 | JW Pharmaceutical | Phase 1 |
| Completed | Effects of Green Tea Extract on Obese Women With High Level of LDL NCT02116517 | National Yang Ming Chiao Tung University | Phase 3 |
| Completed | Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects NCT01375764 | Amgen | Phase 2 |
| Completed | Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Cur NCT01375777 | Amgen | Phase 2 |
| Completed | LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibit NCT01380730 | Amgen | Phase 2 |
| Unknown | Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients NCT01386853 | Tai Tien Pharmaceuticals Co., Ltd. | Phase 3 |
| Completed | Expanding Comparative Effectiveness Research (CER) Capability Through Complex Patient Relationship Management NCT01391585 | Denver Health and Hospital Authority | N/A |
| Completed | The Health Access and Recovery Peer Program NCT01725815 | Emory University | N/A |
| Completed | Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on Inflammation NCT01550432 | Stanford University | N/A |
| Completed | Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg) NCT01353404 | Samyang Biopharmaceuticals Corporation | Phase 1 |
| Completed | The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia NCT01360567 | Taipei City Hospital | Phase 3 |
| Completed | Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia NCT01442987 | Hanmi Pharmaceutical Company Limited | Phase 3 |
| Completed | Study of Medical Assistant Health Coaching in Primary Care for Patients With Chronic Conditions NCT01220336 | University of California, San Francisco | N/A |
| Completed | Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia NCT01327014 | Beijing Peking University WBL Biotech Co., Ltd. | Phase 2 |
| Completed | Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia NCT01349010 | Otsuka Beijing Research Institute | Phase 3 |
| Completed | Vitamin D and Omega-3 Inhibit Metabolic Syndrome NCT01326442 | University of Guelph | Phase 3 |
| Completed | Home-based Exercise for Management of HIV-associated Cardiovascular Disease Risk NCT01377064 | University of South Carolina | Phase 1 |
| Unknown | Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume NCT01382277 | Peking University First Hospital | Phase 4 |
| Completed | Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intol NCT01279590 | Furiex Pharmaceuticals, Inc | Phase 2 |
| Completed | A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551) NCT01236430 | Organon and Co | Phase 1 |
| Unknown | Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and NCT01564875 | Hanmi Pharmaceutical Company Limited | Phase 4 |
| Completed | Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress NCT01267227 | University of Mississippi Medical Center | Phase 2 / Phase 3 |
| Unknown | The Effect of Providing Free Samples of Generic Cardiovascular Medications to Physicians NCT00761904 | Brigham and Women's Hospital | N/A |
| Completed | The Effect of Avocado on Cardiovascular Disease (CVD) Risk Factors NCT01235832 | Penn State University | N/A |
| Completed | Telephone Based Management of Hyperlipidemia NCT01212159 | Temple University | Phase 4 |
| Completed | A Pilot Study to Improve Patient-Doctor Communication NCT01606930 | Walter Reed National Military Medical Center | N/A |
| Unknown | Jiangzhuo Prescription ，Fenofibrate and Placebo in the Treatment of Hyperlipidemia (Syndrome of Phlegm Obstruc NCT01265160 | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | — |
| Completed | Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy NCT01239004 | Radiant Research | Phase 4 |
| Withdrawn | A Pilot Study on the Effect of Vitamin D Treatment in Patients With Statin-Associated Myalgia NCT01274104 | Avera McKennan Hospital & University Health Center | Phase 1 |
| Completed | Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols NCT01131832 | University of Manitoba | Phase 4 |
| Completed | A Human Trial to Evaluate the Efficacy and Safety of Aged Garlic Powder on Improvement of Blood Lipids in Subj NCT01402102 | Chonbuk National University Hospital | Phase 2 / Phase 3 |
| Completed | Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults NCT00955903 | University of Alabama at Birmingham | Phase 3 |
| Completed | Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E NCT01133522 | Amgen | Phase 1 |
| Completed | Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation NCT01332747 | Jamia Hamdard University | Phase 2 |
| Completed | The Health Outcomes Management and Evaluation (HOME) Study NCT01228032 | Emory University | Phase 3 |
| Completed | Effects of Omega-3 Fatty Acids on the Human Gene Expression NCT01089231 | Gottfried Wilhelm Leibniz Universität Hannover | Phase 4 |
| Completed | Eating Peanuts for Health NCT01886326 | Purdue University | N/A |
| Completed | Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness NCT02029989 | University of Minnesota | N/A |
| Completed | Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans NCT01056549 | University Health Network, Toronto | N/A |
| Completed | Reducing Risk of Recurrence NCT01122394 | VA Office of Research and Development | N/A |
| Completed | Tri Staple Technology Stapler Used in Gastric Bypass NCT01026103 | Medtronic - MITG | N/A |
| Completed | The Effects of a Mediterranean Diet in Pediatric Hyperlipidemia NCT01308710 | University of California, San Francisco | Phase 1 |
| Completed | Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With NCT01023607 | Harbin Medical University | Phase 4 |
| Completed | Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Sur NCT02730390 | Otsuka Pharmaceutical, Inc., Philippines | — |
| Withdrawn | Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Ris NCT00738985 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Phase 4 |
| Unknown | Vitamin D Retrospective Study and Role With Disease NCT01798030 | Baltimore VA Medical Center | — |
| Completed | A Study Of Nutraceutical Drinks For Cholesterol (Evaluating Effectiveness and Tolerability) NCT01152073 | Healthy Drink Discoveries, Inc. | N/A |
| Completed | Lepticore in Metabolic Syndrome and Weight Loss NCT01046968 | University of Yaounde 1 | Phase 1 / Phase 2 |
| Terminated | IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlip NCT00663234 | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | Phase 1 / Phase 2 |
| Completed | Red Yeast Rice and Phytosterols In Statin Intolerance NCT00897975 | Chestnut Hill Health System | Phase 2 / Phase 3 |
| Completed | Can Cholesterol Lowering Drugs Influence Circulating Omega-3 Fatty Acid Levels NCT00955227 | University of Manitoba | N/A |
| Completed | Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard The NCT00887653 | The Miriam Hospital | Phase 3 |
| Completed | MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use NCT01050465 | University of Missouri-Columbia | N/A |
| Completed | European Study of Cardiovascular Risk NCT00882336 | AstraZeneca | — |
| Completed | Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol). NCT00891124 | AstraZeneca | — |
| Unknown | Improving Antihypertensive and Lipid-Lowering Therapy NCT00876330 | VA Boston Healthcare System | N/A |
| Unknown | Differential Effects of a Diet Supplementation With Plant Sterol Esters on Human Monocytes NCT00928616 | University Hospital, Saarland | N/A |
| Completed | Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyper NCT01414803 | Yonsei University | Phase 4 |
| Completed | Postprandial Effects of Milk and Milk Constituents NCT00917878 | Maastricht University Medical Center | N/A |
| Unknown | Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipida NCT00843661 | Ospedale di Circolo - Fondazione Macchi | Phase 4 |
| Unknown | Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH) NCT00885872 | Chinese PLA General Hospital | Phase 4 |
| Completed | Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone NCT00910988 | Washington University School of Medicine | N/A |
| Completed | Compliance With Treatment For Patients With Hyperlipidemia NCT00828945 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | — |
| Completed | Metabolic Health Benefits of Dairy Protein NCT01761955 | University of Manitoba | Phase 1 |
| Unknown | The Epidemiology of Aortic Diameter in China NCT00820378 | Zhejiang University | — |
| Completed | Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for Overweight NCT00823277 | Holbaek Sygehus | — |
| Completed | Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyp NCT00810979 | Response Pharmaceuticals | Phase 2 |
| Completed | Cardiovascular Health And Risk Modification in Family Health Teams NCT00787306 | University of Toronto | Phase 3 |
| Completed | Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatm NCT00781560 | AstraZeneca | — |
| Unknown | Standard Process 21 Day Purification Program Project NCT00724217 | Logan College of Chiropractic | Phase 1 / Phase 2 |
| Withdrawn | Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART NCT00572429 | University of California, Davis | N/A |
| Completed | Efficacy of Almonds Added to Chronic Statin Therapy NCT00603876 | University of Kansas | Phase 4 |
| Completed | The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL) NCT00713167 | Shahid Beheshti University of Medical Sciences | Phase 2 / Phase 3 |
| Completed | Identification in Obese Patients of the Mechanism Involved in Intramuscular Lipid Accumulation NCT01644942 | University Hospital, Montpellier | N/A |
| Completed | Effects of Hypolipemic Treatment on Adipokines NCT01099176 | Medical University of Silesia | N/A |
| Unknown | Treatment of Hyperlipidemia and Sexual Dysfunction NCT00923676 | University of Campania Luigi Vanvitelli | Phase 4 |
| Completed | Homburg Cream & Sugar Study NCT00628524 | Universität des Saarlandes | — |
| Completed | Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow NCT00634608 | University of Missouri-Columbia | N/A |
| Completed | Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin NCT00630734 | University of Colorado, Denver | Phase 4 |
| Unknown | U-CHAMP: Urban Cardiovascular Health Assessment and Management Program NCT00626041 | University of Calgary | N/A |
| Completed | A Controlled Trial of High Dietary Fiber Intake on Serum Lipids NCT00593632 | The Cleveland Clinic | N/A |
| Completed | Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED) NCT00723723 | Organon and Co | — |
| Completed | Safety of a Hypolipidemic Agent in Healthy Normal Volunteers NCT00685737 | Pharmena North America | Phase 1 |
| Completed | Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients Wit NCT00973115 | Hanmi Pharmaceutical Company Limited | Phase 3 |
| Completed | Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Hea NCT00552747 | National Heart Institute, Mexico | Phase 4 |
| Completed | Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS NCT00559962 | Aegerion Pharmaceuticals, Inc. | Phase 2 |
| Completed | Lipid Metabolism in Gestational Diabetes NCT00534105 | Baystate Medical Center | — |
| Completed | A Study to Evaluate the Lipid Regulating Effects of TRIA-662 NCT00758303 | Cortria Corporation | Phase 2 / Phase 3 |
| Completed | Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With H NCT00701883 | Gilead Sciences | Phase 2 |
| Completed | Community Based Multiple Risk Factors Intervention Strategy NCT00490672 | Ministry of Health, Malaysia | Phase 4 |
| Completed | Biosynthesis of PGD2 in Vivo NCT01275300 | University of Pennsylvania | N/A |
| Completed | Body Worlds 3 Nutrition Display NCT00669500 | Oregon Health and Science University | N/A |
| Completed | Diabetic Under 70 (Diabetics Below 70) NCT00516204 | AstraZeneca | — |
| Completed | Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function NCT00654459 | Federico II University | — |
| Unknown | Pitavastatin on Carotid Intima-media Thickness NCT00711919 | Kyoto Prefectural University of Medicine | N/A |
| Completed | Portfolio 5 - Multicentre Dietary Advice on Serum Lipids in Hyperlipidemia NCT00438425 | University of Toronto | N/A |
| Terminated | Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis NCT00477191 | Massachusetts General Hospital | N/A |
| Completed | Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2) NCT00652431 | Organon and Co | Phase 1 |
| Unknown | ICA-CHAMP: Indo-Central Asian Cardiovascular Health Assessment and Management Program NCT00627159 | University of Calgary | N/A |
| Completed | Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabet NCT00484419 | Daiichi Sankyo | Phase 3 |
| Completed | Efficacy and Safety of Geneferm Nattokinase NCT00749801 | Chi Mei Medical Hospital | N/A |
| Unknown | The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome NCT00518960 | Health Enhancement Products, Inc. | N/A |
| Completed | An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects NCT00465088 | Abbott | Phase 3 |
| Completed | Effect of MK0524A on Cholesterol Levels (0524A-048) NCT00536510 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Lipoprotein Turnover on Low- and High-MUFA Portfolio Diets NCT00430430 | University of Toronto | Phase 2 |
| Completed | Effects of Dietary Antioxidants on Cardiovascular Risk Factors NCT00756405 | Christopher Gardner | N/A |
| Completed | The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients. NCT00172419 | National Taiwan University Hospital | N/A |
| Completed | Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients NCT00473655 | AstraZeneca | Phase 4 |